Literature DB >> 25216368

Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.

Christopher A Ross1, Alex Pantelyat, Jane Kogan, Jason Brandt.   

Abstract

The clinical syndrome of Huntington's disease (HD) is notable for a triad of motor, cognitive, and emotional features. All HD patients eventually become occupationally disabled; however, the factors that render HD patients unable to maintain employment have not been extensively studied. This review begins by discussing the clinical triad of HD, highlighting the distinction in the motor disorder between involuntary movements, such as chorea, and voluntary movement impairment, with the latter contributing more to functional disability. Cognitive disorder clearly contributes to disability, though the relative contribution compared to motor is difficult to unravel, especially because many of the tests used to asses "cognition" have a strong motor component. The role of emotional changes in disability needs more study. The literature on contributions to functional disability, driving impairment, and nursing home placement is reviewed. Relevant experience is presented from the long-standing JHU HD observational study on motor versus cognitive onset, as well as on cognitive and motor features at the time when individuals discontinued working. Finally, we briefly review government policies in several countries on disability determination. We interpret the data from our own studies and from the literature to indicate that there is usually a close relationship between cognitive and motor dysfunction, and that it is critical to take both into consideration in determining disability.
© 2014 International Parkinson and Movement Disorder Society. © 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  CAG repeat; Chorea; driving; motor impairment

Mesh:

Year:  2014        PMID: 25216368      PMCID: PMC4197404          DOI: 10.1002/mds.26012

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

Review 1.  The primate basal ganglia: parallel and integrative networks.

Authors:  Suzanne N Haber
Journal:  J Chem Neuroanat       Date:  2003-12       Impact factor: 3.052

2.  Automobile driving in Huntington's disease.

Authors:  G W Rebok; F W Bylsma; P M Keyl; J Brandt; S E Folstein
Journal:  Mov Disord       Date:  1995-11       Impact factor: 10.338

Review 3.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

4.  On-road driving impairments in Huntington disease.

Authors:  Hannes Devos; Alice Nieuwboer; Wim Vandenberghe; Mark Tant; Willy De Weerdt; Ergun Y Uc
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

5.  The measurement of abnormal movement: methods developed for Huntington's disease.

Authors:  S E Folstein; B Jensen; R J Leigh; M F Folstein
Journal:  Neurobehav Toxicol Teratol       Date:  1983 Nov-Dec

6.  Health-related quality of life in Huntington's disease: Which factors matter most?

Authors:  Aileen K Ho; Abigail S Gilbert; Sarah L Mason; Anna O Goodman; Roger A Barker
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

7.  Differential cognitive impairment in Alzheimer's disease and Huntington's disease.

Authors:  J Brandt; S E Folstein; M F Folstein
Journal:  Ann Neurol       Date:  1988-06       Impact factor: 10.422

8.  Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion".

Authors:  Jason Brandt; Anjeli B Inscore; Julianna Ward; Barnett Shpritz; Adam Rosenblatt; Russell L Margolis; Christopher A Ross
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2008       Impact factor: 2.198

9.  Correlates of early disability in Huntington's disease.

Authors:  R Mayeux; Y Stern; A Herman; L Greenbaum; S Fahn
Journal:  Ann Neurol       Date:  1986-12       Impact factor: 10.422

10.  A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.

Authors:  Tua Vinther-Jensen; Ida U Larsen; Lena E Hjermind; Esben Budtz-Jørgensen; Troels T Nielsen; Anne Nørremølle; Jørgen E Nielsen; Asmus Vogel
Journal:  Orphanet J Rare Dis       Date:  2014-07-17       Impact factor: 4.123

View more
  28 in total

1.  Inhibiting pathologically active ADAM10 rescues synaptic and cognitive decline in Huntington's disease.

Authors:  Elena Vezzoli; Ilaria Caron; Francesca Talpo; Dario Besusso; Paola Conforti; Elisa Battaglia; Elisa Sogne; Andrea Falqui; Lara Petricca; Margherita Verani; Paola Martufi; Andrea Caricasole; Alberto Bresciani; Ottavia Cecchetti; Pia Rivetti di Val Cervo; Giulio Sancini; Olaf Riess; Hoa Nguyen; Lisa Seipold; Paul Saftig; Gerardo Biella; Elena Cattaneo; Chiara Zuccato
Journal:  J Clin Invest       Date:  2019-05-06       Impact factor: 14.808

Review 2.  The Efficacy and Safety of Pridopidine on Treatment of Patients with Huntington's Disease: A Systematic Review and Meta-Analysis.

Authors:  Moamen Mostafa Asla; Asmaa Ahmed Nawar; Alaa Abdelsalam; Esraa Elsayed; Marwa Abdelazim Rizk; Mohamed Alaa Hussein; Walaa A Kamel
Journal:  Mov Disord Clin Pract       Date:  2021-10-29

3.  COX REGRESSION WITH EXCLUSION FREQUENCY-BASED WEIGHTS TO IDENTIFY NEUROIMAGING MARKERS RELEVANT TO HUNTINGTON'S DISEASE ONSET.

Authors:  Tanya P Garcia; Samuel Müller
Journal:  Ann Appl Stat       Date:  2017-01-05       Impact factor: 2.083

4.  Dynamic landmark prediction for mixture data.

Authors:  Tanya P Garcia; Layla Parast
Journal:  Biostatistics       Date:  2021-07-17       Impact factor: 5.899

5.  Psychiatric Aspects of Dementia.

Authors:  Chiadi U Onyike
Journal:  Continuum (Minneap Minn)       Date:  2016-04

Review 6.  Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease.

Authors:  Md Zeeshan Rasheed; Heena Tabassum; Suhel Parvez
Journal:  Protoplasma       Date:  2016-01-29       Impact factor: 3.356

7.  How different aspects of motor dysfunction influence day-to-day function in huntington's disease.

Authors:  Noelle E Carlozzi; Stephen G Schilling; Nicholas R Boileau; Kelvin L Chou; Joel S Perlmutter; Samuel Frank; Michael K McCormack; Julie C Stout; Jane S Paulsen; Jin-Shei Lai; Praveen Dayalu
Journal:  Mov Disord       Date:  2019-10-14       Impact factor: 10.338

8.  Pridopidine for the Improvement of Motor Function in Patients With Huntington's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Shujun Chen; Tianyu Liang; Tao Xue; Shouru Xue; Qun Xue
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

9.  Disease Progression in Huntington Disease: An Analysis of Multiple Longitudinal Outcomes.

Authors:  Tanya P Garcia; Yuanjia Wang; Ira Shoulson; Jane S Paulsen; Karen Marder
Journal:  J Huntingtons Dis       Date:  2018

10.  Interrater Reliability of the Unified Huntington's Disease Rating Scale-Total Motor Score Certification.

Authors:  Jessica Y Winder; Raymund A C Roos; Jean-Marc Burgunder; Johan Marinus; Ralf Reilmann
Journal:  Mov Disord Clin Pract       Date:  2018-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.